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ABBREVIATIONS 
 
WHO  - World Health Organisation 
CVD  - Cardio Vascular Disease 
NCMH - National Commission on Macro Economics and Health 
NHANES - National Health And Nutrition Survey 
BMI  - Body Mass Index 
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PPAR - Peroxisome Proliferator – Activated Receptor 
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PAI -1 - Plasminogen Activator Inhibitor -1 
HMG 
CoA Reductase - 3 Hydroxy – 3 Methyl – Glutaryl – CoA Reductase 
IL – 6  - Interleukin – 6 
TNF – ∞ - Tumour Necrosis Factor Alpha 
LP  - Lipoprotein 
LPL  - Lipoprotein Lipase 
LCAT - Lecithin Cholesterol Acyl Transferase  
TGL  - Triglyceride 
TC  - Total Cholesterol 
VLDL - Very Low Density Lipoprotein 
LDL  - Low Density Lipoprotein 
IDL  - Intermediate Density Lipoprotein 
HDL  - High Density Lipoprotein 
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INTRODUCTION 
 
Heart disease is the most important cause of death and sickness  in 
developing countries like India.
1
  In women, those under the age of 50, Cardiac 
disease is unusual in the absence of  disease such as diabetes or hypertension. The 
first step in assessing disease  of coronary vessels  in females is by introducing  
awareness of its existence-both among doctors and female themselves.
2 
Diseased 
Coronary arteries usually present atypically in females.
3
Unusual anginal 
presentation is more common than MI. NCMH (National Commission on 
Macroeconomics and Health ) of India, according to this Commission, there would 
be around 62 million patients with arterial disease of the heart  occur within 2015 
in India and of 23 million people of them would be younger than age of 40 years.
4 
 
Coronary vascular disease is mainly  due to atherosclerotic process 
affecting  various sized arteries  of the heart and abnormally high fat in blood has 
been found to be one of the most important factor contributing to vascular 
narrowing and hypoperfusion.
5
 WHO defines overweight and obesity as conditions 
in which the body accumulates fat to the extent that health and well-being are 
affected very much.
6 
With  obesity and weight above normal, the prevalence of 
high BP, high lipid level, and high blood sugar  increases substantially and are 
considered to be three factors on the pathway to CV disease and mortality.
7,8
  
Central adiposity is one of the best predictor of Vascular Disease of the 
heart  independently of other major risk factors.It can be considered  important risk 
  
factor when added with Body Mass Index (BMI).
9 
The relationship among them  is 
mediated by a modification /resistance produced by insulin on the metabolism 
lipids.
10
Individuals who presented “centrally  obese” (e.g., with a high Waist 
circumference and WH Ratio ) will have high serum lipid levels 
11 
These 
observations has been noticed in a variety of populations all over the world 
specific  in developed
12
 and less developed countries.
13
  
 
Apart from its interest for establishing a physiopathological causal link, this 
predictive association suggests the possibility of measuring one or more 
anthropometric indices of central adiposity as a first step in population screening 
for high lipid level in blood.
14 
 
BMI when used alone as a anthropometric measurement is inadequate to 
differentiate between fat and fat-free individuals. Other anthropometric 
measurements which measures central obesity like WC, WHR should be added 
with BMI to assess dyslipidemia and future risk of CVD
15 
  
  
In our cross-sectional study we studied the pattern of hyperlipidemia and its 
correlation with Waist Circumference and Body Mass Index(BMI) among healthy, 
asymptomatic female patients attending out patient department in CMCH, 
Coimbatore. 
            
 
  
  
AIM OF THE STUDY 
 
The study aims to identify the prevalence of  dyslipidemia  in 
asymptomatic female patients attending master health checkup  in 
Coimbatore Medical College hospital. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                     
  
  
OBJECTIVES 
 
 
 
• To assess the prevalence of hyperlipidemia among healthy females 
 
• To analyze the significance between hyperlipidemia and anthropometric 
indices including WC,WHR and BMI. 
 
• To correlate lipid subfractions  with anthropometric measures. 
 
• To find out the distribution of dyslipidemia in female population according 
to their age,physical activity and personal habits. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
REVIEW OF LITERATURE 
 
  Heart Disease (CVD) is now the most common cause of death worldwide 
now. In 2010, Heart disease mainly coronary disease caused 16 million deaths 
worldwide (30%).This includes  nearly 40% of deaths in developed countries and 
28% in developing countries like India
16 
. The overall variation in cardiac disease 
rates is related to ethinic, genetic, environmental and regional variations in risk 
behaviours. Worldwide, high lipid levels are estimated to play a role in 56% of 
ischemic  disease of heart and 18% of, cerebrovascular accidents, accounting to 
4.4 million deaths per annum. In 2008, age standardized mean total cholesterol 
was 179.4 mg/dl in men and 184.2 mg/dl in women
17
. 
 
       Obesity is increasing throughout the world, particularly in developing 
countries .Three risk factors for CAD are hypertension, dyslipidemia, and cigarette 
smoking
18
. All these can be preventable and able to treat. In recent times, more 
importance  has been focused on treatment of cholesterol mainly through 
behavioural modifications ,traditional diet and   by drugs. The various drugs,i.e  
statins, fibrates and glitazars (PPAR modulators).  Each of them, attacking 
metabolism of lipids at various state through its own mechanism. The HMG-CoA 
reductase is the enzyme which is the rate limiting step in lipid synthetic pathway. 
The inhibitors in this pathway (Hydroxy, Methyl Glutaryl co-A) are often called to 
as “statins“,continue to be the main treatment in hyperlipidemia. 
 
PHYSIOLOGY OF LIPID METABOLISM 
  
Lipids are consumed in the form of neutral fats which are also known as 
triglycerides. Triglycerides are made up of glycerol nucleus and free fatty acids. 
Triglycerides form the major constituent in foods in animal origin and much less in 
foods of plant origin. Apart from triglycerides, usual diet also contains small 
quantities of cholesterol and cholesterol esters.  
 
Dietary fats are classified into two types: 
1. Saturated fatty acids 
2. Unsaturated fatty acids. 
 
Saturated fats contain triglycerides which has maximum amount of hydrogen 
ions without any double bonds between carbon atom. It is rich in full fat milk, 
meat, cheese, baked biscuit, coconut oil, palm oil and deep fried fast foods. 
 
Unsaturated FA formed by dehydrogenation of saturated FA. It can be 
classified into 3 types: 
1. Monounsaturated fats 
2. Polyunsaturated fats 
3. Trans fats. 
 
 
 
Monounsaturated fats which contains on double bond between the carbon 
atoms and it is rich in nuts(cashews, almonds, hazelnuts and peanuts), peanut oil 
and margarine. 
 
  
Polyunsaturated fats which contains more than one double bond between 
the carbon atoms. It is rich in fruits, vegetables, walnuts, fish, sea foods and egg. 
 
Polyunsaturated fats are of two types: 1.Omega -3 fats  2. Omega -6 fats. 
Both Omega -3 fats and Omega -6 fats are beneficial to the body. However, 
consuming too much of Omega -6 fats results in hazards than benefits. 
  
  
DIGESTION OF LIPIDS 
Area Juice Enzyme Substrate End product 
Mouth Saliva Lingual lipase Triglycerides 
Fatty acid 1, 2-
diacylglycerol 
 
Stomach 
Gastric 
juice 
Gastric 
lipase(weak 
lipase) 
Triglycerides 
Fatty acids 
Glycerol 
 
 
 
 
 
 
 
 
Small 
intestine 
 
 
 
 
 
 
 
 
Pancreatic 
juice 
Pancreatic lipase Triglycerides 
Monoglycerides 
Fatty acids 
Cholesterol ester 
hydrolase 
Cholesterol 
ester 
Free cholesterol 
Fatty acids 
 
Phospholipase A Phospholipids 
Lysophospholipids 
 
Phospholipase B 
Lyso 
Phospholipids 
Phosphoryl choline 
Free fatty acids 
 
Colipase 
Facilitates 
action of 
Pancreatic 
lipase 
--- 
 
Bile-salt 
activated lipase 
Phospholipids 
Lysophospholipids 
 
Cholesterol 
esters 
Cholesterol and 
fatty acids 
 
Succus 
entericus 
Intestinal lipase Triglycerides 
Fatty acids 
glycerol (weak 
action) 
 
TABLE1:DIGESTION OF LIPIDS IN THE BODY 
 
  
Trans fats which contain trans double bond between carbon atoms and it is 
rich in milk, cheese, lamb and beef.   
 
Bile salts also involved in the digestion of lipids. The final end products are 
FA, cholesterol and monoglycerides. They are absorbed from the micelles enters 
the intestinal mucosal cells by simple diffusion and re-esterified to triglycerides 
and cholesterol esters. They form chylomicrons which cannot pass through 
membranes of the capillaries because of its larger size they enter the lymphatic 
lymph vesssels. The lipids are stored in the adipose tissues in the form of 
triglycerides. Obesity does not depend on the body weight but on the amount of 
body fat. 
 
ADIPOSE TISSUE  
Adipose tissue or fat is a loose connective tissue that forms the storage site 
of fat in the form of triacylglycerol.Adipose tissue is of two types, white and 
brown adipose tissue. 
 
WHITE ADIPOSE TISSUE 
It is distributed underneath the skin ,forms subcutaneous fat and also 
surround the internal organs.These fat cells are unilocular i.e contain one single 
large vacuole filled with fat.It has three functions1.storage of energy which is 
under the control of insulin.2.Heat insulation.3.Protection of internal organs by 
acting as mechanical insulator. 
 
  
  
BROWN ADIPOSE TISSUE 
It is a specialized form which has the function opposite to white adipose 
tissue.It is present over the areas in the back of neck and inter scapular region . It is 
forming 5% of total tissue during infancy ,disappears gradually  and forms only 
1%of total adipose tissue in aduts.These cells are multilocular.i.e,contains many 
small vacuoles flied with fat.The colouration is due to  large number of iron rich 
mitochondria.It function are 1.nonshivering thermogenesis-very essential in 
infants.2.functions as mitochontrial uncoupling of protein and produces heat and 
these are called as thermogenin. 
 
 
  
 PATHOPHYSIOLOGY 
FIG 1: ROLE OF ADIPOSE TISSUE IN DYSLIPIDEMIA
 
True adipokines such as leptons and 
by adipose tissue.  
 
Visceral adipose tissue CETP, PAI
6. Obesity can be due to chronic low grade inflammation characterized by elevated 
plasma levels of inflammatory markers. Exce
persons. This state of inflammation ma
with obesity such as dyslipidemia, insulin resistance and atherosclerosis.
 
Increased state of inflammation
PAI-1,Leptin,IL-6,TNF
Endothelial 
dysfunction
insulin resistance
 
OF ADIPOSE TISSUE
 
adiponectin, are produced exclusively 
-1,angiotensinogen, adiponec
pt adiponectin which is low in obese 
y contributes to health problems associated 
 
Excess adipose tissue
-alpha,Angiotensinogen
ATHEROSCLEROSIS
Increased 
CETP(cholesterolester 
transfer protein)
Dyslipidemia
 
 
 
tin and IL-
 
  
TABLE 2: FUNCTIONS OF ADIPOKINES 
 
 
Adipokines 
 
Functions 
Adiponectin 
Anti-inflammatory, 
Insulin sensitizer 
Leptin Regulate appetite and energy expenditure 
Platelet activator inhibitor-1 
Contributes to the prothrombotic state, 
proinflammatory 
TNF-alpha 
Impairs the insulin signaling cascade, 
Inducing insulin resistance 
Contributes to proinflammatory state 
IL-6 
Stimulates CRP release from the liver 
Causes insulin resistance 
Contributes to proinflammatory state 
 
  
  
PATHOPHYSIOLOGY OF LIPID METABOLISM 
Cholesterol Homeostasis  
 
Cholesterol is an essential cell membrane component and it is derived from  
steroid hormones and bile acids. Sources of cholesterol are produced by the body 
itself and from ingested foods, which is necessary to carry out normal functioning 
of life.Blood cholesterol levels approximately 40-60% from endogenous source, 
remaining from dietary sources. 
 
 Triglycerides  are  synthesized in the body  mainly from diet rich in 
carbohydrates . In the liver ,the fatty acids  can be esterified  with glycerol  and 
stored
19
. Lipids, triglycerides  and cholesterol are transported in the blood by 
combining with lipoproteins which are  spherical in its  nature.These Lipoproteins 
(LP) depending on their composition it was categorized into five major classes
20
. 
 
Among the classes, LDL constitutes for approximately 60%-70% of total 
serum cholesterol. HDL constitutes 20-30% of total serum cholesterol and VLDL 
constitutes about 10-15%.Vascular diseases of the heart are the most prevalent and 
preventable cause of death and disability both in developed as well as developing 
countries.The higher death in CAD found among South Asians. According to 
NMCH, (National Commission on Macroeconomics and Health) ,In India the 
prevalence of CAD by 2015 would be around 62 million and of these, 23 million 
would be patients less than 40 yrs of age group. Dyslipidemia causes 
atherosclerotic deposition of large and medium sized arteries. It has been found to 
be one of the most contributing factor for CAD. 
  
 
  According to size of particle size, Chylomicrons are the largest one. 
Intermediate density lipoprotein (IDL), Low Density Lipoprotein (LDL) ,High 
Density Liporotein (HDL)are smaller in that order. The particles which are larger 
one have TGL rich ,the smaller density particles have cholesterol ester rich core
21
. 
 
  
  
 
 
 
 
 
 
 
 
FIG 2: STRUCTURE OF LIPOPROTEINS 
 
 
Category 
 
Composition 
 
Origin 
 
Chylomicrons Exogenous triglycerides 
Gut 
 
Very low density                  
lipoproteins 
Triglycerides 
Liver 
 
Intermediate density 
lipoproteins 
Cholesterol esters and 
triglycerides 
VLDL/HDL 
Low density lipoproteins Cholesterol VLDL catabolism 
High density lipoproteins Cholesterol 
Liver, gut 
 
 
TABLE 3: CHARACTERISTICS OF THE MAJOR CLASSES OF 
LIPOPROTEINS. 
 
 
  
  
Functions of lipoproteins; 
Lipoproteins are involved in transport of  free fatty acids in blood in 
combination with albumin. 
 
 
LIPOPROTEINS 
 
FUNCTIONS 
VLDL 
 
Transports Triglycerides from liver to adipose 
tissue 
IDL 
 
Transports Triglycerides ,Cholesterol and 
phospholipids from liver to peripheral tissue 
LDL 
 
Transports Cholesterol and phospholipids from 
liver to tissues and organs like Heart 
HDL 
 
Transports Cholesterol and phospholipids from  
tissues and organs like Heart back to Liver 
 
TABLE 4: FUNCTIONS OF LIPOPROTEINS. 
  
FIG 3:  SOURCES OF CHOLESTEROL 
 
1. Exogeneous cholesterol derived from systemic circulation. 
2.Endogenous cholesterol synthesized within the cell
22
.  
 
 
  
In the first pathway, dietary fat is digested ,then absorbed in proximal part  
of small intestine.After absorbtion ,they are transformed to chylomicrons which 
are made up of fatty acids, cholesterol, and apolipoproteins.  
 
 In the endogenous pathway, lipoprotein  are mainly involved in the 
synthesis,  transport in   blood and catabolism of chylomicron particles and 
remnants
23
. They are all reformulated in the intestinal endothelium where they are 
all packed into These chylomicrons then enter and transported via  the lymphatic 
system.In the capillary beds,it can be  metabolized by the enzyme called 
lipoprotein lipase (LPL).  
 
    These chylomicrons acted upon by lipoprotein lipase break  into 
chylomicron remnants which contain less fatty acids and apolipoprotein B-48 Apo-
E .These remnant proteins are cleared from blood via LDL receptor  protein in the 
liver.
25 
 
    In the second  pathway, cells can synthesis their own cholesterol from  
acetyl- CoA  through series of biochemical reaction. 
. 
 
  
 
FIG 4: CHOLESTEROL SYNTHESIS PATHWAY 
 
    Acetyl-coA is converted into HMG-CoA by an enzyme called HMG-
CoA synthetase.It  can converted to mevalonate,then farnesyl pp ,squalene, 
lanosterol and finally become cholesterol through serial enzymatic reactions.The 
enzymes involved are HMG CoA synthase and HMG CoA reductase . 
 
     The inhibitors of HMG-CoA reductase reduce the production of 
cholesterol in the cell,by competitively inhibiting this enzyme
23
. 
 
       VLDL, LDL, HDL. are the three major lipoprotein involved in 
endogenous pathway. 
Cholesterol and fatty acids  enter the endogenous pathway. Triglycerides  
produced in the presence of excess of carbohydrates are secreted into blood stream 
(VLDL). These contain 
  
o apolipoprotein B-100, 
o apoproteins E,  
o apoproteins C-11 along with triglycerides and      
           cholesterol. These VLDL contains five times   
           more TGL than cholesterol.  
 
 Apoprotein B and E - link with B-E or LDL cell surface receptors. 
Apolipoprotein C-II - cofactor for the enzyme lipoprotein lipase (LPL). 
 
The FFA are used for energy production primarily by cardiac and skeletal 
muscle and  stored in fat cells.
 
FIG 5:FATE OF TRIGLYCERIDES 
Triglyceride molecules hydrolysed by the enzyme LPL.This process of 
lipolysis decreases the content and the size of VLDL.It enters either of the two 
pathways  
 
1.Hepatic Clearence  
TGL VLDL IDL LDL
  
2.Transformation to IDL.  
 
IDL contains almost all the cholesterol present in the VLDL.TGL content is 
high in IDL particles. LPL and Hepatic lipase, convert them  into LDL (rich in 
cholesterol). Only apolipoproteins E and C removed.This IDL particles have 
shorter life span as they are intermediate products of VLDL and LDL. Cholesterol 
measurements are not significantly impacted by cholesterol and triglyceride 
contents. In IDL particles, cholesterol circulates less than 5%, except for rare 
dyslipidemias. IDL particles are cleared from circulation and are converted to LDL 
receptor and LDL. 
 
LDL penetrates into subendothelial tissue contributing to the development 
of atherosclerosis. LDL particle penetrates more into subendothelial tissue, when 
its smaller. Cholesterol gets deposited outside the cell, when there is excessive 
circulation of  LDL cholesterol. This deposition of  LDL cholesterol causes plaque 
formation in the endothelium and narrowing of  Coronary Arteries. According to 
recent developments, CHD risk is highly found in two specific types of LDL 
particles-1.lipoprotein(a) protein. 
 
2.atherogenic lipoprotein phenotype B, which is quite dense.     This 
subclass has high risk of CHD and is found in approximately 30% of the 
population. 
 
HDL is the third major lipoprotein that is involved in endogenous pathway. 
HDL particles are rich in cholesterol and are smaller in size than LDL. HDL are 
  
involved in transport of cholesterol from intestine to liver and has antiatherogenic 
potential. Cholesterol that are deposited within arterial wall might be removed or 
prevented by HDL. Other benefits of HDL are:         
 FIG 6: FUNCTIONS OF HDL 
 
Works as anti-oxidant and prevents LDL oxidation. 
Reduces aggregation and activation of platelets  by producing more 
prostacyclin. Facilitates fibrinolysis by stabilizing  prostacyclin levels in serum. 
Competitively inhibits the LDL uptake by endothelium.. 
 
Aggregation  and uptake of LDL by macrophages are prevented. 
Production of cholesterol and foam cell is reduced. 
 
HDL reduces with the increase in triglycerides.hence it is a marker of 
altered metabolism of VLDL and chylomicrons
26
. 
  
Transportation of cholesterol to the liver from the periphery involves two 
key enzymes and they are eliminated by HDL particles. 
 
IDL and VLDL are eliminated through liver.  
 The three lipoproteins play a role in peripheral  utilization of TGL and 
cholesterol from the liver  and vice versa for elimination. 
 
Insufficient requirement of cholesterol by the cell will increase the 
production of LDL receptor and this will moves to the area on the cell surface 
called coated pits, where the cells identify lipoproteins which contain apo E or B  
present in VLDL, IDL and LDL .The binding affinity for LDL receptors are more 
for VLDL and IDL. Because it contains both Apo B and E. when binding occurs 
on the surface, internalization of the lipoprotein  by cell occurs, action of 
liposomes takes place where it is broken down and used by the cell. The LDL 
receptor protein again returns comes back to the surface of the cell and the process 
continuously repeated. 
 
  
Cholesterol 
in HDL
through 
LCAT
cholesterol 
esters
LCAT- lecithin cholesterol acyl transferase 
  
RELATIONSHIP BETWEEN CHOLESTEROL AND CHD 
The relationship between lipids and lipoproteins with coronary disease is 
still in controversy and research .The initiating factors of plaque formation are 1. 
The entry of LDL and Lp(a)  into the sub-endothelial space 2. oxidatively modified 
free radicals produced by smooth muscle cells,  
3.activated macrophages 4. Vascular endothelial cells.  
These lipoproteins are oxidatively modified. It is taken up by the 
macrophages via scavenger receptor pathway. this process yields foam cells which 
are rich in lipids.  
 
The next step is the fatty streak formation.It is formed of oxidatively 
modified lipoproteins and the foam cells. The muscle cells moves to 
subendothelial space and its proliferation occurs  within the intima, ultimately 
leading to atherogenesis.lesions continue to grow by increased smooth muscle  and 
collagen synthesis.At one point, foam cell undergo necrosis  and extracellular lipid 
core forms,  it triggers an autoimmune response, causing T lymphocyte infiltration 
into advential layer of blood vessel.this completes the process of atherogenesis,the 
main factor involved in CHD. 
 
CAUSE OF ALTERED LIPID METABOLISM 
By excessive secretion of VLDL 
By impaired lipolysis of triglyceride rich lipoproteins 
By impaired hepatic uptake apo-B containing lipoproteins 
  
Secondary causes-liver disorders, drugs, hypothyroidism nephritic 
syndrome, autoimmune diseases, malnutrition, anorexia nervosa,diabetes mellitus 
type-2, obesity, menopause, stress, pregnancy, renal failure, acromegaly, cushing’s 
syndrome, glycogen storage disease, acute intermittent porphyria. 
 
SUBCLINICAL HYPOTHYROIDISM AND DYSLIPIDEMIA 
Various randomized studies observe rise in total cholesterol, LDL and 
serum triglyceride in subclinical hypothyroid patients. This association is more 
strongly found in females, with increasing age and those with baseline TSH >12 
mlU/ L. It also associated with increased intima and media thickness, endothelial 
dysfunction, systolic and diastolic dysfunction leads to cardiovascular risk. 
Coronary heart diseases are more with TSH >10mlU/ L
24
. 
The American Thyroid Association has set  guidelines for  evaluation of 
patients with symptoms  and with known thyroid problems. 
Screening is suggested for  
1. Women  from the age of 35, 
2. at 5-year intervals, for individuals with a strong family history of  
    thyroid disease,  
 
3. Elderly  
4. Women at 4-8 weeks postpartum 
5. Patients with autoimmune illnesses. 
Screening of asymptomatic patients are not recommended. Early evaluation 
of people with even subtle signs and symptoms are encouraged.  
  
The American College of Physicians  guidelines for screening thyroid 
disease recommends TSH levels monitoring only in women over 50 years. 
Because in younger population, the prevalence of asymptomatic thyroid is low. It 
recommended treatment only in symptomatic and hyperlipidemic  patients, with 2 
to 5 yearly follow up.  
 
 
CARDIOVASCULAR DISEASES AND STROKE IN WOMEN 
Estrogens and androgens  have major effects on the cardiovascular system 
and metabolism of lipids. 
   Estrogens-increases high-density lipoprotein lowers low-density lipoprotein  
(direct vasodilator effects on the vascular endothelium, 
enhances insulin sensitivity  antioxidant and anti-inflammatory)
26 
Androgens- have the opposite effect- decrease HDL, increases LDL.  Hence 
the rate of CHD increases after both surgical and natural menopause. The most 
  
common presentation of MI in women is cardiac arrest or cardiogenic shock. In 
men, it mostly presents as ventricular tachycardias. 
 
Younger women has higher mortality rates than with men of similar age. 
This mortality gap has greatly fallen because of the advent of percutaneous 
transluminant coronary angioplasty. There  are lower rate of restenosis and a better 
long term outcome.  
 
RISK FACTORS FOR CHD IN MEN AND WOMEN: 
Elevated cholesterol levels,  
Low HDL cholesterol, 
Obesity,  
Smoking,  
Lack of physical activity,  
Hypertension and diabetes mellitus  
IMPORTANT RISK FACTORS IN WOMEN: 
 Total triglyceride levels are an independent risk factor. 
 Low HDL cholesterol 
 Diabetes mellitus 
Smoking-accelerates atherosclerosis and has negative effect on cardiac 
function, causes early menopause are  more important risk factors for CHD in 
women than in man.    
 
  
According to National Health and Nutrition Survey(NHANES), prevalence 
rates both coronary heart disease and stroke have increased in the 1994-2004 
compared to the 1988-1994 NHANES, whereas prevalence rates have decreased 
or remained unchanged in men. These increases were paralleled by an increasing 
prevalence of abdominal obesity and other components of metabolic syndrome. 
 
CLASSIFICATION OF DYLIPIDEMIA 
Dyslipidemia may be caused by primary genetic predisposition or by 
secondary causes and most of the times the combination of both. There are three 
major forms of dyslipidemia- 
                         Hypercholesterolemia,  
                         Hypertriglyceridemia  and  
                         Mixed (combination of both) 
 In all these cases there is either increase in number or the compostion of  
specific lipoproteins.this is the major determinant in selecting the appropriate drug 
therapy. 
  
  
TABLE 5:FREDRICKSON CLASSIFICATION OF 
HYPERLIPOPROTEINEMIAS 
 
 
  
  
Familial Hypercholesterolemia (FH): 
FH is characterized by- elevated LDL-C with normal TGL leading to 
premature coronary atherosclerosis ,tendon xanthomas.  The elevated levels of 
LDL-Chloesterol  in FH is due to increased synthesis and  decreased catabolism of 
LDL. There were two mutated LDL receptor alleles Homozygote and 
Heterozygote.  In  this FH  Heterozygote are less affected than FH  Homozygote.  
According to LDL-receptor  activity they can be classified into receptor negative 
(<2% of normal LDL receptor activity), receptor defective (2-25% of LDL 
receptor activity).  
 
In  Homozygote FH, total cholesterol levels are usually >500 mg/dl and 
even >1000 mg/dl.  FH causes atherosclerosis in early life, leading  to vascular 
diseases and death in childhood.  Atherosclerosis initially develops in one of the 
aortic root leading to valvular stenosis and it can extends into ostia of the coronary 
vessels, which leads to stenosis. 
 
In Heterozygous FH, hypercholesterolemia presents since birth, but it 
cannot be detected until adulthood. It produces corneal arcus, tendon xanthoma 
and CAD. The tendon xanthomas present over the elbows, knees, dorsum of the 
hands and over the Achilles tendons in~75% of patients.  
 
FH Heterozygotes who presented with high LP (a) are associated with 
increased  risk of vascular complications especially in heart.  In untreated men it 
can causes MI in  ~50%  of persons below the age of 60years.  In females it can 
leads to CAD ,but it can manifest only at later ages.Although the age of onset of 
  
atherosclerotic heart disease is late in women with FH, coronary heart 
disease(CHD) is significantly more commen in women with FH in the Female 
population. No specific diagnostic is not available to detect heterozygous FH. 
 
Hypertriglyceridemia produced by elevated levels of VLDL or chylomicron 
particles. It can be 1.Primary hypertriglyceridemia by the excessive production 
from diet   
 
2. Secondary hypertriglyceridemia, following obesity , diabetes and other 
chronic medical diseases. 
 
Hypertriglyceridemia is not an isolated one it can associated with low HDL 
and elevated LDL can lead to accelerated atheroscelerotic deposition in the 
vascular endothelium.  
 
Mixed hyperlipidemias - most common forms of  dyslipidemia  presented 
with  both triglyceride and cholesterol  in high levels. 
 
In Familial combined hyperlipidemia; It can be characterized by increased 
ApolipoproteinB, Overproduction of VLDL, elevated TGL and high LDL. It 
occurs 1 in every 100 in the population it has various presentation  within the 
family members they can presented with hypercholesterolemia and high TGL leads 
to vascular disease in the heart.  
 
 
 Mixed hyperlipidemia
deficiency.It has reduced delipidization of VLDL and chylomicrons and causes 
elevated triglyceride  which leads to increased risk of pancreatitis.
treatment should be  to reduce triglyceride 
 
DYSLIPEDEMIA IN DIABETES 
Diabetes produces the following changes in the vascular endothelium
 
FIG 7: ROLE OF DIABETES MELLITUS IN ATHEROSCLEROSIS
                                     
  
 
Diabetic dyslipidemia can be diagnosed by lipid profile after 10
fasting. It is characterized small dense LDL. ApoB level is more informative but 
its estimation is not readily available in most of the hospitals. Non HDL 
cholesterol estimation can be used in such situations. 
Accelerated atheroscelerosis , accumulation of oxidised LDL
Oxidative stress, LDL oxidation
Increased production of glycated end products and reactive oxygen species
Genetic expression of various  genes
Activation of nuclear factor (NF
 
 also has familial lipoprotein lipase(LPL) enzyme 
The aim  of 
 level and prevention of  pancreatitis. 
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Action of Insulin on lipids 
Physiologically, insulin inhibits lipolysis. In insulin deficiency/resistance 
the following changes takes place leading to atherosclerotic disorders 
 
FIG 8:ROLE OF INSULIN IN ATHEROSCLEROSIS 
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HYPERDLIPEDEMIA IN HYPERTENSION:  
In hypertensive patients the following changes takes place which leads to 
deposition of cholesterol in blood vessels. 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
Fig : Role of Hypertension in Atherosclerosis 
 
Women with CAD have poor prognosis because atherosclerotic plaque 
(made up of cellular and fibrous tissue), on erosion and rupture leads to 
thrombogenesis and vascular occlusion. After CABG, they had poor outcome 
because of relatively small coronary vessels than man, more left ventricular 
hypertrophy. They have atypical presentation of angina . 
  
(microvascular), made difficulty in evaluation. Advantages of female sex can be 
eliminated by diabetes,obesity and distribution of fat in women can also risk factor 
for CAD.  According to NCEP ATP III,guidelines  are formed to identify and 
manage hyperlipidemia.    
 
PREVENTION AND CONTROL OF OBESITY AND DYSLIPIDEMIA 
According to WHO expert committee 1995 maintaining weight by 
prevention of weight gain of more than 5kg in all people. In those who are already 
overweight, 5-10% of body weight reduction is the initial goal. Prevention should 
begin in early childhood. It is difficult to treat obesity in adults than in children. 
This can be achieved by (a) life style management, (b) pharmacotherapy. 
 
Life Style Management 
1. Diet therapy: 
• Diet rich in fruits, vegetables, fibers and whole  grain. Two 
servings of fish rich in omega-3 fatty acids per week. 
 
• Reducing sodium < 2300mg/day. 
 
• 45-65% of calories from carbohydrates 20-35% of daily calories 
from fat and (saturated fats to <10% of the daily calories) and 10-
35% from protein. 
 
 
• Fibre intake: >50yrs - 38gm (men), 25gm (women) , <50yrs -  
30gm (men) 21gm  (women). 
  
 
• Types of energy reduced diets: 1.Very low calorie diet -  provides 
<800kcal/day, liquid meal fortified with minerals. It is 
recommended for morbidly obese and those who need rapid weight 
loss. 2. Low calorie diet – supplies 1200-1600kcal/day. It consists 
of traditional low calorie diet, prepackaged foods fortified with 
minerals. It provides nutritionally balanced low fat, low energy 
meal.
5555
 
 
• Special nutrients – 1.Oat fibre, 2.Conjugated linoleic acids – 
decreasing lipid synthesis, increasing lipolysis 3. Whey protein – 
rich in essential, branched chain aminoacids. 
 
1. Physical activity:  
                      According to Physical activity 2008 guidelines, 150 minutes /week 
of moderate exercises or 75 minutes /week –vigorous ,aerobic exercises. 
 
2.  Behaviour therapy:  
          Stress management, avoid eating in front of television, introducing 
new diet/physical exercises. 
 
 
 
 
3. Medical management:                                                                      
1.Centrally and peripherally acting Anorexins,Endocannabinods and newer 
drugs Bupropion+naltrexone/bopropion+zonisamide,fenfluramine, 
  
Lorcaserin,Orlistat,Phenttermine,Rominabsnt,Sibutramine and 
Tesofensine(under trial), 
 
 2. High and moderate intensity statin therapy.  
High intensity statin 
therapy 
Moderate intensity statin 
therapy 
 
Daily dose lowers LDL-C on 
average by approximately > 50% 
 
Daily dose lowers LDL-C on 
average by approximately 30 -
50% 
 
Atorvastatin – 40-80mg 
Rosuvastatin – 20-40mg 
 
Atorvastatin – 10-20mg 
Rosuvastatin – 5-10mg 
Simvastatin – 20-40mg 
Pravastatin – 40-80mg 
Lovastatin – 40mg 
Pitavastatin – 2-4mg 
 
TABLE 6: STATIN THERAPY 
 
 
 
3.  Non statin drugs like fibrates, nicotinic acid and omega-3 fatty acids. 
National Lipid Association (NLA) recommendation for  management of 
lipidemia:  Elevated ApoB containing lipoproteins (non HDL-C and LDL-
C) are atherogenic cholesterol which focus on non HDL-C – (triglyceride 
management) in the non fasting state. 
  
   
4. Alternative medicine:  
Green tea contains catechine, (antiobesogenic), hydrocitric acid present in 
Indian fruit Garcinia cambogia
61
. 
 
5.  Surgical management:  
Indications: BMI >40kg/m
2 
or BMI >35 kg/m
2
 with comorbidities such as 
Hypertensive, hyperlipidemia  severe arthrosis and DM
31
. 
 
Surgical procedures for obesity seems to have potential for changing the 
current concepts of pathophysiology and management of metabolism.  
 
  
  
BARIATRIC SURGERIES 
 
 
 
FIG 10: VARIOUS BARIATRIC SURGERIES 
   
 
 
 
 
 
  
Bariatric procedures
Restrictive 
procedures
Laproscopic adjustable 
gastric band
Laproscopic sleeve 
gastrectomy
Malabsorbtive 
procedures
Biliopancreatic 
diversion
BPD with duodenal 
switch
Combined 
procedures
Roux-en-Y Gastric 
bypass (RYGBP)
Long limb  RYGBP
  
STUDIES 
STUDY 1:    TABLE 7 
STUDIED BY  Ghosh A et al
32 
TOPIC Corelation between WHR and 
TC,FPG,FTGL 
STUDY 
POPULATION 
130 bengalee 
WHR <0.95( CENTRALLY 
NON OBESE-CNO) 
N=47 
 Higher TC(p<0.05) FPG (p 
< 0.01) and FTG (p < 0.05) 
WHR>0.95( 
CENTRALLY OBESE-CO) 
 N=83 
RESULT CO status had a significant effect 
(p < 0.05) on TC, VLDL-C, FPG and 
FTG.  
 
STUDY 2:  TABLE 8 
 
STUDIED BY  Asha Mahilmaran et al
33 
TOPIC Corelation between BMI,WHR,TC 
with age  
STUDY 
POPULATION 
2318 people above 20 years at 
apollo hospital Chennai 
Total cholesterol (TC) >200mg/dl was present in 36%, 
HDL,<40mg/dl (males), <50mg/dl (females) in 37%, LDL> 130mg/dl 
in 25%, triglyceride(TGL) > 150mg/dl in 41 % of the people. (p-0.001) 
RESULT Significant increase in BMI, WHR 
after the age of 30 years (p,0.00I).  
 
  
   Mohan V et al
34
 conducted a study on 1167 subjects residing in the 
residential areas of 2 industries (Indian Airlines and Integral Coach Factory) in 
Chennai in southern India. Diabetes was found in 11.9%; hypertension in 25.4%; 
dyslipdemia in 40.2%; hypertriglyceridemia in 28.3%; overweight (body mass 
index > or = 23 kg/m2) in 60.2%; and metabolic syndrome in 34.1%. Use of 
tobacco in any form was present in 22.9% of men and 0.5% of women. 
STUDY 3:  TABLE 9 
STUDIED BY  Gupta R et al
35 
TOPIC Prevalence (%) of cardiovascular 
risk factors in men and women had the 
habit of smoking/tobacco use 
STUDY 
POPULATION 
1091  
Prevalence (%) of cardiovascular risk factors in men and women 
had the habit of smoking/tobacco use in 37.6 and 11.6, 
 hypertension in 37.0 and 37.6%,  
overnight and obesity in 37.8 and 50.3, 
 truncal obesity in 57.3 and 68.0,  
high cholesterol > or = 200 mg/dl in 37.4 and 45.8, high 
triglycerides > or = 150 mg/dl in 32.3 and 28.6  
 metabolic syndrome in 22.9 and 31.6 percent. 
RESULT Significant increase in 
hypertension, obesity and metabolic 
syndrome among tobacco users. 
 
 
  
STUDY 4: TABLE 10 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
STUDIED BY  Gupta R et al
36 
TOPIC Prevalence of dyslipidemia 
STUDY 
POPULATION 
234 physicians 
 
Prevalence of high total cholesterol levels > or = 200 mg/dl was 
in 91 (44.8%) males and 10 (32.3%) females.  
High LDL cholesterol level (> or = 100 mg/dl) was in 144 
(70.9%) males and 22 (70.9%) females. 
LDL levels > or 130 mg/dl in 70 (34.5%) males and 9 (29.0%) 
female physicians. 
 High triglyceride levels (> or = 200 mg/dl) were in 38 (18.7%) 
males and 4 (12.9%) female. 
RESULT Significant prevalence of 
dyslipidemia among physicians 
  
STUDY 5: TABLE 11 
 
         
 
 
 
 
 
 
 
 
 
 
 
Arijit De et al
38
 conduted a population-based study on 1005 persons. A total 
of 280 (27.9%) persons from the study population, were found to be hypertensive, 
of which 151(54%) persons were found to be dyslipidemic. Both males ans 
females hypertensives had significantly higher values  of total cholesterol, TG, 
LDL-C as compared to control(p<0.001). 
    
  
STUDIED BY  Misra A et al
37 
TOPIC Correlation ofBMI, WHR with 
lipid profile 
STUDY 
POPULATION 
532 subjects 
high waist-hip ratio (WHR) in 9.4% (95% CI 5.4-14.8) of males, 
51.1% (95% CI 45.8-56.3) of the females 
RESULT In both males and females BMI, 
WHR were positive predictors of 
biochemical parameters except for HDL 
cholesterol. 
  
STUDY 6: Table 12 
 
      
 
 
 
 
 
STUDIED BY  Chadha DS et al
39 
TOPIC Correlation BMI,WHR and lipid 
profile 
STUDY 
POPULATION 
From aug 2005 to Jan 2006 at the 
Air Force Central Medical Establishment, 
New Delhi.  
Hypertriglyceridemia (36%) was the commonest abnormality 
noted followed by low HDL-C levels (18%). Lipid subfraction analysis 
revealed that cholesterol and LDL-C correlated to BMI(r=0.2,p=0.002) 
and body fat% (r=0.16,p=0.020). in older men, BMI correlated 
positively with elevated cholesterol (r=0.36,p<0.001) while WHR  
correlated positively with triglycerides (r=0.42,p=0.001). 
RESULT Combination of anthropometric 
variables predicts dyslipidemia better in 
asymptomatic healthy males than anyone 
particular variable. 
  
STUDY 7: TABLE 13 
 
      
 
 
 
 
 
 
 
 
 
  
STUDIED BY  AM Savant et al
40 
TOPIC Correlation BMI,WHR and lipid profile 
STUDY 
POPULATION 
1085, a retrospective study in 2006 at 
P.D.Hinduja National Hospital and 
Medical research Center, Mumbai, India. 
TC concentration 200 mg/dl, 38.7% were males and 23.3% were 
females. HDL-C was abnormally low in 64.2% males and 33.8% in 
females. 
RESULT  The increase of prevalence of  
hypercholesterolemia and 
hypertriglyceridemia was more prominent 
in 31-40 age group than in 30 age group. 
  
STUDY 8: TABLE 14 
 
         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
STUDIED BY  Latheef SA et al
41
  
TOPIC Correlation hypertension,obesity and 
lipid profile 
STUDY 
POPULATION 
1519  
urban population of Tirupati 
central obesity- 1003 (66%) [male 320 (59.4) and females 683 
(41.12%)], 
 Low HDL cholesterol -709 (46.67%) [male 284 (52.69%) and 
females 425 (43.36%)],  High triglyceride levels (>or= 150 mg/dl) 444 
(29.2%)[(males 173 (32.09%) and females 272 (27.75%), 
 high cholesterol levels (>or=200 mg/dl) [(males 127 (23.56%) 
and females 278 (28.36%) 
 hypertension 396 (26.06%) [males 149 (27.64%) and females 
247 (25.20%)]. 
 
RESULT Central obesity and hypertension are 
positively correlated to high TGL,TC and 
low HDL.  
  
STUDY 9:TABLE 15 
 
        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
STUDIED BY  Chow CK et al
42 
TOPIC Mean levels of total, LDL, HDL-
cholesterol and triglycerides in 
population if Asian definitions are used. 
STUDY 
POPULATION 
4535 
rural Andhra Pradesh 
mean levels of total, LDL, HDL-cholesterol and triglycerides 
were 4.5 (4.4-4.6) mmol/L, 2.8 (2.7-2.9) mmol/L, 3.0 (3.0-3.1) 
mmol/L, 1.2 (1.16-1.22) mmol/L,  1.3 (1.2-1.4) mmol/L for women.  
18.4% of men and 26.3% of women were overnight rising to 
32.4% of men and 41.4% of women if ‘Asian’ definitions were used. 
 Criteria for NCEP-ATPIII metabolic syndrome were met by 
26.9% of men and 18.4% of women with figures of 32.5%  and 23.9%, 
respectively, if ‘Asian’ waist cut-offs were substituted. 
RESULT Asian weight cut offs gives more refined 
values for Indian population.  
  
STUDY 10: TABLE 16 
 
 
 
 
STUDIED BY  Gupta R et al
43 
TOPIC Correlation between  
STUDY 
POPULATION 
1123 adults aged  >20 years in an 
urban Indian population in Jaipur Heart 
watch study-2. 
Obesity, body mass index > or = 27 kg / m2 was present in 135 
males (24.5%) and 173 females (30.2%). Truncal obesity (waist :hip > 0.9 
males, >0.8 females) was found in  316 males (57.4%) and 392 females 
(68.4%). 
The most  comman dyslipidemia in both males and females was 
low HDL-cholesterol (<40 mg/dl: males 54.9%, females 54.2%). High 
total cholesterol levels of > or = 200mg/dl (males 37.4%, females 54.2%). 
High LDL-cholesterol levels of > or =130 mg/dl (males 37.0%, 
females 45.8%) and high levels of triglycerides > or = 150 mg/dl (males 
32.3%, females 28.6%) were also seen in a significant number. 
RESULT Most common dyslipidemia is low HDL, 
followed by high TGL and high TC and 
LDL. 
  
 
Waisr JS et al
44
 studied 2050 adult Asian Indian subjects residing in two 
metropolitan cities and found that hypertriglyceridemia (>150 mg/dl) in 20.2% and 
low levels of HDL-C (<40 in males; <50 mg/dl in females) in 55%. 
 
Gupta A et al
45
 studied 1091 urban Indian population aged 20 years and 
above, and it was found that among men and women high triglycerides in 32.1 and 
28.6%, low HDL cholesterol in 54.9 and 90.2%; central obesity in 21.8 and 44.0% 
of individuals. 
 
Gupta A et al
46
 studied 1127 adults aged  >20 years and found that among 
men and women obesity (BMI>or=25 kg/m2) in 303 (54.5%) and 350 (61.3%), 
truncal obesity (high WHR) in 339 (61.0%) and 310 (54.30%), hypertension in 
322 (57.9%) and 279 (48.9%), high total cholesterol>or=200 mg/dl in 111 (32.6%) 
and 120 (39.5%), low HDL cholesterol<40mg/dl in 103 (30.3%) and 83 (27.3%), 
high triglycerides>or=150mg/dl in 146 (42.9%) and 132 (43.4%). 
 
Gupta R et al
47
 studied 1091 adults > 20 years in Indian urban population, 
central obesity (waist, men > 102 cm, women >88cm) was found in 116 (25.6%) 
and 246 (44.0%); low HDL cholesterol (men,40mg/dl, <1.0mmol/l), women<50 
mg/dl, <1.3mmol/l) in 292 (54.9%) and 504 (90.2%); high triglycerides >/=150 
mg/dl (>/=1.7mmol/dl) in 172 (32.3%) and 160 (28.6%). 
 
Gupta R et al
48
 examined 458 persons in Jaipur Heart watch study-3 and 
found that hypercholesterolemia (total cholesterol > or = 200mg/dl) in 75 (33.2) 
and 67 (28.9%), high triglycerides in 55 (24.3%) and 34 (14.7%), low high-density 
  
lipoprotein cholesterol in 169 (74.8%) and 155 (66.8%),among men and women. 
There was significant linear relationship of body mass index with prevalence of 
hypercholesterolemia. 
 
Gupta R et al
49
 studied (in 1995)2212 subjects and 1123 subjects(in 2002) 
in an Indian urban population and found that , In men, high total cholesterol > or = 
200mg/dl was in 24.6% vs. 37.4%, high LDL cholesterol > or = 130 mg/dl in 22.1 
vs. 37.0%, high triglycerides > or = 150 mg/dl in 26.6  vs. 30.6%  and low HDL 
cholesterol < 40 mg/dl in 43.2 vs.  54.9%; while in women these were in 22.5 vs. 
43.1%, 28.6 vs. 45.1%, 28.6 vs. 28.7% and 45.9 vs. 54.2% respectively. 
 
 
                       
 
 
 
 
 
 
 
 
 
 
  
METHODOLOGY 
Design and Data collection 
This was a cross sectional study. The study was  undertaken on the female 
subjects approaching the outpatient department of the Coimbatore Medical College 
Hospital, Coimbatore between  September 2014 – August 2015.  The study is 
proposed to be conducted after obtaining consent from the subjects. 
 
Inclusion criteria 
• Healthy female subjects without comorbid illness 
• Age group between 25-60yrs 
 
Exclusion criteria 
• Diabetes mellitus 
• Hypertension 
• Ischemic heart disease 
• Chronic renal disease 
• Chronic liver disease 
• Hypothyroidism  
• Patients on lipid lowering drug 
  
Information was collected about demographics (age, gender and occupation), 
anthropometric measurements (body Wt, Ht, BMI, WC, hip circumference and 
WHR), personal habits of dietary pattern (veg/mixed), alcohol intake(quantity), 
tobacco chewing and smoking and clinical parameters (BP, FBS, ECG) ,previous 
drug intake and F/H of diabetes, hypertension, ischemic heart disease).  Blood 
collected by puncturing vein after  8-10 hours of overnight fasting.It was collected 
in red topped plain tubes for analysis. Routine urine analysis was carried out on the 
same day and ECG was taken for those who were found to be dyslipidemic. 
 
Patients were interviewed as per the prepared Proforma and then complete 
clinical examination was done. 
 
Blood  Glucose  and lipid subfraction Analysis 
Blood samples are analysed  by using  automatic analyser. Blood glucose 
calculated by GOD-POD END POINT Trinder’s method. TC was measured by 
DYNAMIC EXTENDED STABILITY CHOD-PAP METHOD, Triglyceride 
(TGL) concentrations were measured by  TC was measured by DYNAMIC 
EXTENDED STABILITY CHOD-PAP METHOD, Triglyceride (TGL) 
concentrations were measured by DYNAMIC EXTENDED STABILITY WITH 
LIPID CLEARING AGENT GPO-TRINDER METHOD. IFCC approved 
enzymatic methods are used. LDL was estimated by Friedward’s formula, VLDL 
was calculated by dividing TGL by Five. 
 
  
Definitions and Cut off points of hyperlipidemia 
According to NCEP- ATP III Guidelines  ,serum lipid fractions are 
categorized into:1.Hypercholesterolemia  defined as TC > 200mg/dl 
2 LDL-C as > 100mg/dl, 
3. Hypertriglyceridemia as TGL > 150mg/dl 
According to ADA,.FBS  > 126mg/dl /on anti diabetic drugs were 
considered as Diabetes Mellitus. 
 
Statistical Analysis 
Age, Anthropometric measurements, Serum Lipid subfraction and fasting 
glucose levels measured were calculated by using  -mean + SD. The data collcted 
were again categorized according to two age groups .By using Chi square test, 
Unpaired t test was applied in comparisons of independent and dependent 
proportions. A p value <0.05 was considered deemed significant. Results were 
expressed as percentages. 
 
 
                                     
  
  
RESULTS 
The study population was comprised of 100 asymptomatic females aged 
between 25-40years. 
TABLE 17: DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF 
THE STUDY POPULATION 
Parameter Means SD+ P Value 
Age 30.76 4.73 - 
Weight 59.43 7.67 >0.05 
Height 158.23 5.88 >0.05 
BMI 23.69 2.69 <0.01 
WC 78.82 2.71 <0.01 
WHR 0.87 0.05 <0.05 
Systolic BP 117.70 9.23 - 
Diastolic BP 78.08 5.90 - 
 
Unpaired t test was applied 
P < 0.05 is significant 
      In 100 asymptomatic females studied, the mean age of the females was 
30.76 + 4.73. The mean weight was 59.43 + 7.67. Mean BMI found was 23.69 + 
2.69kg/m
2
. Mean waist circumference were 78.82 + 2.71 cms. The mean waist hip 
ratio were 0.87 + 0.05, whereas the mean systolic and diastolic BP was 117.70+ 
9.23mmHg and 78.08 + 5.90mmHg respectively. There was significant difference 
between means of BMI (P value <0.01), WC (P value <0.01), and WHR (P value 
<0.05). 
  
TABLE 18: BIOCHEMICAL CHARACTERISTICS OF THE STUDY 
POPULATION 
Parameter Means SD+ P Value 
TC 169.54 24.33 >0.05 
TGL 134.27 19.73 >0.05 
LDL 103.85 24.45 >0.05 
HDL 39.85 5.91 >0.05 
VLDL 24.52 14.16 0.02 
FBS 98.99 12.04 >0.05 
 
 
Mean cholesterol found were 169.54 + 24.33mg/dl., whereas the mean 
triglycerides were 134.27 + 19.73mg/dl. The mean LDL,HDL,VLDL were 103.85  
+ 24.45, 39.85 + 5.91 and 24.52 + 14.16mg/dl. The mean fasting blood sugar was 
98.99 + 12.04. There was significant difference between means of VLDL (P value 
0.02). 
 
 
 
  
 TABLE 19: DISTRIBUTION OF LIPID PROFILE AMONG 
ASYMPTOMATIC FEMALES
Lipid profile
Dyslipidemia
   
FIG 11
Among 100 asymptomatic females, 43% were found to be dyslipidemic.
Remaining 57% were normolipidemic.
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 TABLE 20: DISTRIBUTION OF BMI AMONG ASYMPTOMATIC 
BMI 
Obesity 
Overweight 
Normal 
 
FIG
 
Among 100 asymptomatic females 41 were found to be 
were obese, 33 were found to be over weight.
 
 
          
 
 
FEMALES 
<30Yrs 31 to 40Yrs 
11 15 
21 12 
29 12 
 12: DISTRIBUTION OF BMI 
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 TABLE 21: DISTRIBUTION OF WC AMONG ASYMPTOMATIC 
WC 
Abnormal
Normal 
 
Among 100 asymptomatic females, 76 were 
Circumference, 24 were found to be abnormal.
 
 
    
 
 
FEMALES 
<30Yrs 31 to 40Yrs 
 9 15 
52 24 
 
FIG 13: DISTRIBUTION OF WC 
found to be normal Waist 
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 TABLE 22: PATTERN OF DYSLIPIDEMIA IN ASYMPTOMATIC 
Parameter
TC>200 
TGL>150
LDL>100
HDL<40
 
FIG 14
 
In 100 asymptomatic females studied, the HDL was <40mg/dl is 55, 
followed by TGL >150mg /dl in 25, the TC  >200mg/dl and LDL >100mg/dl were 
16 each. 
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TABLE 23  : DISTRIBUTION OF   BMI AND DYSLIPIDEMIA 
 
 
DYSLIPEDEMIA TOTAL 
YES NO 
No. % 
No. % No. % 
BMI 
Obese (>25) 24 92.3 2 7.7  26 100.0 
Over wt  
(22.5-25) 
7 21.2 26 78.8 33 100.0 
Normal 
(<=22.5) 
13 31.7 28 68.3 41 100.0 
TOTAL 44 44.0 56 56.0 100 100.0 
 
Dyslipidemia was present in 92.3% of obese persons, 21.2% of overweight 
persons and 31.7% of normal BMI persons. There was significant correlation 
between BMI and abnormal lipid profile.(P value <0.01) 
 
 
 
 
 
 
  
  
TABLE  24 :DISTRIBUTION OF WC AND DYSLIPIDEMIA 
 
 
DYSLIPEDEMIA TOTAL 
YES NO No. % 
No. % No. % 
WC 
Above Normal 
(>80) 
22 91.7 2 8.3 24 100.0 
Normal (<=80) 
22 28.9 54 71.1 76 100.0 
TOTAL 44 44.0 56 56.0 100 100.0 
 
Abnormal Waist circumference was seen in 91.7% of the study 
population,it has significance with dyslipidemia. (P value<0.01) 
 
 
 
 
 
  
  
TABLE 25: DISTRIBUTION OF DYSLIPIDEMIA  
BASED ON AGE 
Parameter 
Age 
<30Yrs 31 to 40Yrs 
No % No % 
TC 8 13.1 8 13.1 
TGL 13 21.3 12 30.8 
LDL 8 13.1 8 13.1 
HDL 31 50.8 24 61.5 
 
Among 100 asymptomatic females, low HDL and high TGL were found to 
be higher in 31-40years age group than below 30years age group. 61.5% were 
found to be low HDL in 31-40years age group, 50.8% were below 30years. 
 
 
 
 
 
  
  
TABLE 26: INCIDENCE OF DIABETES AND IMPAIRED FASTING 
GLUCOSE IN ASYMPTOMATIC FEMALES 
 
 
 
Age TOTAL 
30 YRS OR 
BELOW 
31-40 YRS 
No. % 
No. % No. % 
FBS 
>126 2 3.3 3 7.7 5 5.0 
110-126 3 4.9 3 7.7 6 6.0 
<110 56 91.8 33 84.6 89 89.0 
TOTAL 61 100.0 39 100.0 100 100.0 
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FIG 15: INCIDENCE OF DIABETES AND IMPAIRED FASTING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Out of 100 asymptomatic females studied,
Among them 3.3 percent were below 30 years,7.7 percent were  in 31
group. However there was no statistical 
 
 
 
 
 
 
 
 
 
No. %
31-40 YRS No. %
TOTAL
FBS >126
FBS 110-126
FBS <110
TOTAL
GLUCOSE 
 Diabetes was found in 5 percent. 
significance (P value >0.05). 
-40 year age 
  
TABLE 27: AGE SPECIFIC DISTRIBUTION OF CORONARY RISK 
FACTORS AMONG STUDY POPULATION 
 
Characteristics 
Age group 
P Value 
<30Yrs (61) 31 to 40Yrs (39) 
Hypercholesterolemia 
(>200mg/dl)  
8(13.1) 8(20.5) >0.05 
Hypertriglyceridemia 
(>150mg/dl) 
13(21.3) 12(30.8) 
 
>0.05 
High LDL 
(>100mg/dl) 
8(13.1) 8(20.5) 
 
>0.05 
 
Low HDL 
(<40mg/dl) 
31(50.8) 24(61.5) 
 
>0.05 
High FBS 
(>126mg/dl) 
2(3.3) 3(7.7) >0.05 
High WC (>80cm) 9(14.8) 15(38.5) <0.05 
High W/H Ratio 
(>0.80cm) 
61(100) 39(100) - 
High BMI 
(>25kg/m
2
) 
11(18) 15(38.5) >0.05 
High BP 
(>130/85mmHg) 
6(9.8) 8(20.5) >0.05 
 
  
There was 61 asymptomatic females in the age group of < 30years 
compared with 39 in 31-40years age group. The low HDL (<40mg/dl) was high 
among 31-40years age group (P value >0.05). WC was also higher in 31-40years 
age group. (P value <0.05). High BMI was found in age group 31-40years (P value 
>0.05). High BP was found in age group 31-40years (P value >0.05). WC has 
statistical significance (P value <0.05) among 31-40years age group. 
 
  
  
TABLE 28: CORONARY RISK FACTORS AND HABITS 
Parameter 
Tobacco chewer 
(n=26) 
 
Non tobacco      
chewer(n=74) 
 
P Value 
TC>200 9 7 <0.01 
TGL>150 16 9 <0.01 
LDL>100 9 7 <0.01 
HDL<40 6 49 <0.01 
WC>80cm 15 9 <0.01 
WHR>0.7 26 74 - 
BMI>25 17 9 <0.01 
 
Parameter 
Alcoholic 
n=8 
Non alcoholic 
n=92 
P Value 
TC>200 4 12 <0.05 
TGL>150 6 19 
         <0.01 
LDL>100 4 12 
<0.05 
HDL<40 1 54 <0.05 
WC>80cm 8 16 <0.01 
WHR>0.7 8 92 - 
BMI>25 6 20 <0.01 
 
  
Parameter Veg 
n=16 
Mixed 
n=84 
P Value 
TC>200 7 9 <0.01 
TGL>150 11 14        <0.01 
LDL>100 7 9 <0.01 
HDL<40 4 51 <0.01 
WC>80cm 10 14 <0.01 
WHR>0.7 16 84 - 
BMI>25 11 15 <0.01 
        
 
In 100 asympyomatic females,26 were chewing tobacco,8 were alcoholic,16 
were vegetarians.Dyslipidemia was found to be significant in tobacco chewers (P 
value <0.01)  and alcoholic  (P value <0.05) .BMI and  WC were higher in tobacco 
chewer  ( P value <0.01). 
 
WC was higher in those who had vegetarian diet  (P value <0.01)  .BMI and 
WC were higher in alcoholic  ( P value <0.01). 
 
  
  
TABLE 29: PEARSON CORRELATION COEFFICIENT ANALYSIS OF 
VARIABLES OBESITY AND DYSLIPIDEMIA 
 
 DYSLIPIDEMIA 
BMI Pearson Correlation 0.393
**
 
WC Pearson Correlation 0.549
**
 
WHR Pearson Correlation        0.260
*
 
 
**.Significance at  0.01 level. 
*Significance  at 0.05 level. 
There was significant correlation between BMI, WC and WHR. Among 
them, BMI and Waist Circumference were significant at P value <0.01. 
 
 
 
 
 
  
  
TABLE 30: PEARSON CORRELATION COEFFICIENT ANALYSIS 
OF VARIABLES OBESITY AND LIPID PROFILE 
 
 TC TGL LDL HDL 
BMI 
Pearson 
Correlation 
.396
**
 .597
**
 .421
**
 -.330
**
 
WC 
Pearson 
Correlation 
.646
**
 .664
**
 .703
**
 -.529
**
 
WHR 
Pearson 
Correlation 
.204
*
 .369
**
 .236
*
 -.268
**
 
 
** Significance  at  0.01 level. 
*  Significance  at  0.05 level. 
Pearson correlation coefficient analysis showed significant correlation 
between BMI with TGL(P<0.01), LDL(P<0.01), HDL(P<0.01). Waist 
Circumference had significant correlation with TC(P<0.01), TGL(P<0.01), 
LDL(P<0.01).  
 
 
       
 
  
  
TABLE 31: PEARSON CORRELATION COEFFICIENT ANALYSIS OF 
LIPID SUBFRACTIONS TO VARIABLES OF OBESITY IN VARIOUS 
AGE GROUPS 
 
Variables  <30yrs 31-40yrs 
Total 
cholesterol 
BMI 0.323
* 
0.451
** 
WC 0.734
** 
0.551
** 
WHR 0.196 0.161 
Triglycerides 
BMI 0.530** 0.690** 
WC 0.789
** 
0.690
** 
WHR 0.349
** 
0.382
* 
LDL  
BMI 0.349
** 
0.482
** 
WC 0.789
** 
0.626
** 
WHR 0.247 0.185 
HDL 
BMI -0.212 -0.606
** 
WC -0.430
** 
-0.743
** 
WHR -0.255
* 
-0.339
* 
  
There was significant correlation between BMI and WC with total 
cholesterol (r = 0.323 and r = 0.734, p <0.05, triglycerides (r = 0.530 and r = 0.789, 
p <0.01) in <30yrs age group. BMI, WC were significantly correlated with HDL (r 
= 0.606, p <0.05, r = 0.743, p <0.05) in 31-41yrs age group. TGL and LDL also 
were significantly correlated with BMI, WC and WHR in both age groups. 
 
 
 
 
  
DISCUSSION 
In our study ,a step towards evaluating the blood  level of lipids and 
glucose in asymptomatic females in urban population and identifying these 
coronary risk factors by anthropometric  variables. The study identifies the 
pattern of dyslipidemia such hypercholesterolemia, hypertriglyceridemia and 
abnormally high Low Density Lipoprotein cholesterol(LDL) and low High 
Density Lipoprotein cholesterol (HDL) levels in all age groups, which are 
well known risk factors for CardioVascular Diseases. 
 
Overall prevalence of dyslipidemia was ranged from 10-73% in 
various studies
37
.In our study43% of asymptomatic females were found to be 
dyslipidemic.Our results are consistent with the previous cross sectional 
study conducted among Sudanese women in Khartoum state
25
 and across 
sectional study conducted at Tirupathi41 wherein increased prevalence of 
dyslipidemia  in young females was found to be one of the major contributor 
of Coronary Artery Disease(CAD). 
 
 
 
 
  
Our study which showed that elevated lipid levels were prominent in 
31-40year age group as compared to <30 years,which means the risk of 
dyslipidemia increases as the age advances .In our study, fasting blood sugar 
found to be more in 31-40 year age group and of these  7.7%were found to 
be newly diagnosed Diebetes Mellitus.The remaining subjects with impaired 
fasting blood sugar levels (6%) are on their way to become Diabetic in 
future, which is an important risk factor for CAD.Enas et al,in Coronary 
artery disease in Indians (CADI) study reports the prevalence of diabetes 
mellitus to be three to six times  higher among south Asians than Europeans, 
Americans and other Asians
45
. In our study,Dyslipidemia was found 
significant among tobacco chewers and alcoholics (P value<0.01).This is  
consistence with the study done by Gupta BK et al
50
. 
 
In our study , the most common dyslipidemic pattern observed was 
low HDL  cholesterol(61.5%). These finding is consistant with Jaipur Heart 
Watch-2
51
,Jaipur Heart Watch-3
47
 studies  and cross sectional study which 
was conducted at Tirupati
41
.In our study,low HDL cholesterol was not 
differs significantly between the age group <30 years(50.84%) and 31-
40years(61.5%)37.HDL cholesterol particles are  mainly involved in reverse 
cholesterol transport,leading to antiatherogenic effect.HDL is more specific 
in prevention and removal of cholesterol deposits within the arterial 
  
wall
52
.Low HDL cholesterol levels are stronger predictor of premature  and 
severe Coronary Artery Disease(CAD) and Stroke and its 
recurrence.
54
Increased prevalence of low HDL cholesterol was reported in 
earlier study by Enas et al,who found that only 5% of Asian Indian women 
had optimal HDL levels
53
. 
In  the process of Atherosclerosis,high LDL cholesterol and its 
oxidation has been recognized as primary risk factor for Coronary Artery 
Disease by National Cholesterol Education Programme(NCEP) Adult 
Treatment Plan(ATP)-III.
53
In our study,low LDL  cholesterol was found 
20.5% in31-40 years age group,13.1% among <30 years because of 
unhealthy food habits and life style modifications. 
 
In our study,the second common lipid subfraction contributing to 
dyslipidemia was hypertriglyceridemia which was 30.8% in the age group of 
31-40 years,21.3% among <30 years.The hypertriglyceridemia, 
hypercholesterolemia and high LDL is  a major risk factor of concern in the 
age group of 31-40 years. When compared  to  western population ,Indians 
had relatively low serum cholesterol predispose them to CAD.
55
In Chennai 
based hospital study,the threshold for the TC levels posses the risk for CAD 
was<200mg/dl and 75% of   Myocardial Infarction(MI) patients   had  less 
than 200mg/dl.
40
 Diet rich in fat and high calorie intake ,reduced physical 
  
activity would be the major culprits of Dyslipidemia in our population.Our 
dietary pattern are rich in saturated fats
56
 and also involves destruction of 
nutrients  like folate by overcooking and frying.Reuse of the same  cooking 
oil for frying,refrying leading to transfattyacid formation which probably 
contributes to increase risk of Dyslipidemia in our population.
40
In Canadian 
study, influence of diet on Dyslipidemia was studied by utilizing 3 groups:a 
control group, a group with only dietary modifications and a group that was 
started on statin. After 4 weeks, lipid profile was repeated and compared.A 
drastic reduction  in lipid levels was noted in both diet and statin group than 
control group. However, between them not much variation in lipid 
levels57.Both of them have same effect, and  dietary intervention is a more 
viable option. 
 
In our study, Body Mass Index (BMI) ,Waist Circumference(WC) 
and Waist to Hip Ratio(WHR) correlated with Dyslipidemia in female 
population.Further correlation analysis between BMI and lipid subfraction 
revealed that BMI showed significant correlation with TGL(P<0.01), 
LDL(P<0.01), HDL(P<0.01). Waist Circumference had significant 
correlation with TC(P<0.01), TGL(P<0.01), LDL(P<0.01).WHR also had 
significant correlation with TC (P< 0.05), LDL (P<0.05)and TG 
(P<0.01)These measures were consistent with studies conducted by Chada 
  
DS et al
39
,Misra A et al
37,58
.BMI   was widely used as an indicator of 
obesity ;it has some limitations because it dependent on race,age and  body 
fat percentage.Asians had low BMI and high body fat .Abdominal obesity 
has been significantly associated with CVD risk which has been measured 
by anthropometrics indices like WC and WHR especially in females 
59,60
. In 
Nurses  Health study conducted by Rexrode KM et al,they identified WC 
and WHR both are independent risk factor of  CAD in women.
39 
 
Dyslipidemic persons are more frequently ‘centrally obese’’. 
37
especially females. In our study, BMI,WC and WHR  all are  correlated 
with lipid subfraction analysis. None of the anthropometric measures when 
used alone was able to predict dyslipidemia better. In our country, physicians 
should always consider combination of anthropometric parameters like WC 
and WHR in addition to BMI to assess the cardiometabolic health.   
 
 
                              
  
  
SUMMARY 
 
• Our study was conducted at CMCH Coimbatore from September 
2014 to August 2015. 
• The study population was comprised of 100 asymptomatic 
(resembling healthy) females came for routine screening in master 
health checkup. 
• Overall 43% were found to be dyslipidemic, 57%were 
normolipidemic. 
• Low HDL cholesterol <40mg/dl was the most comman dyslipidemic  
pattern found in 55 persons followed by TG>150, in 25 persons and  
LDL>100, TC>200 found in 16 persons. 
• Lipid subfraction analysis showed  HDL was found in 61.5% in < 31-
40 years age group, 50.8% <30 years age group. 
• 7.7% were found to be diabetic in 31-40years age group, 3.3% <30 
years age group, impaired blood glucose was found in 6% of the total 
study population. 
• Waist Circumference (P value <0.05) was significantly higher in 31-
40 years age group (38.5%) and it was found 14.8% <30 years age 
group. 
 
  
• Hyperlipidemia was found significantly higher (P value <0.01) among 
tobacco chewers and mixed diet persons (P value <0.01). 
• BMI was higher in tobacco chewers (P value <0.01), WC (P value 
<0.01) and those who had mixed diet (P value <0.01) WC was 
significantly correlated with LDL  
• BMI was significantly correlated with total cholesterol (r = 0.451, P 
<0.01), TGL ( r = 0.690, P<0.01), HDL ( r = 0.606, P<0.01), LDL ( r 
= 0.482, P<0.01).  
• WC was significantly  correlated with total cholesterol ( r = 0.734, 
P<0.01, TGL  (r = 0.789, P<0.01),LDL-C (r=0.789, P<0.01) and  with 
HDL(r = 0.430, P<0.01) 
• WHR was significantly correlated with TGL (r = 0.382, P<0.05),HDL 
(r=0.339,P <0.05). 
• BMI  was correlated with HDL(P<0.05) in 31-40years age group. 
• Combination of anthropometric measurements predicted dyslipidemia  
better in asymptomatic adults than anyone particular variable. 
 
 
  
  
LIMITATIONS 
 
 Genetic and secondary causes producing  dyslipidemia were not ruled 
out. 
 Lipoprotein estimation was not done. 
 LDL-C was not estimated separated in those who had high triglyceride 
level 
 Sample size was less due to time constraint. 
 
 
 
 
 
 
 
                              
  
  
CONCLUSION 
 Dyslipidemia is more prevalent in young asymptomatic females being 
more common among 31-40yrs age group 
 Low  HDL Cholesterol was the most common dyslipidemic pattern  
being common in both <30 yrs and 31-40 yrs age group. 
 BMI ,WC and WHR all of them have significant association with lipid 
subfraction analysis. 
 Combination of anthropometric measurements predicted dyslipidemia 
better in asymptomatic females than single one variable. 
 Therapeutic life style changes which is the main component in 
primary and secondary prevention of dyslipidemia. 
 There is increasing trend of obesity and dyslipidemia in asymptomatic 
young females probably because of sedentary life styles. 
 Early preventive measures needed to control overweight and prevent 
the future complications and disabilities. 
 Health education about nutritious diet to be started in childhood will 
change the society into the healthy way. 
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ANNEXURES 
Proforma 
PREVALENCE OF HYPERLIPIDEMIA AMONG HEALTHY FEMALES AND 
THEIR RELATIONSHIP WITH WAIST CIRCUMFERENCE AND BODY MASS 
INDEX 
SL.NO: 
IP.NO: 
NAME OF THE PATIENTS ATTENDER: 
DOE: 
AGE: 
SEX: 
OCCUPATION: 
ADDRESS: 
PRESENTING COMPLAINTS IF ANY: 
HISTORY OF PRESENTING COMPLAINTS IF ANY: 
PAST HISTORY: 
H/O  DM                               YES/NO 
H/O  HIN                              YES/NO 
H/O  IHD                              YES/NO 
H/O  Medication if any       YES/NO 
FAMILY HISTORY: 
Type-II DM,HTN,IHD 
  
PERSONAL HISTORY: 
Diet – veg / mixed 
Appetite – good/poor 
Sleep – sound/disturbed 
Marital status – married/unmarried 
Bowel and Bladder – regular/ altered 
Habits 
Tobacco chewing  :        yes / no             Duration                         
Alcoholic:                           yes / no              Duration                    Amount 
OBSTETRIC & MENSTRUAL HISTORY: 
No of Children: 
LMP: 
Cycles-    regular/irregular. 
PHYSICAL EXAMINATION:  
1. State of nutrition: over weight / normal / underweight 
Wt                                 kg 
Ht                                  mtrs 
BMI                               kg/m2 
2. Waist circumference in cm: 
3. Hip circumference in cm: 
4. Waist to Hip ratio: 
5. Hydration – well hydrated / dehydrated 
6. Eyes- 
7. Pupils:  Reactive/Non reactive 
8. Oral cavity 
  
9. Waist circumference in cm: 
10. Hip circumference in cm: 
11. Waist to Hip ratio: 
12. Hydration – well hydrated / dehydrated 
13. Eyes- 
14. Pupils:  Reactive/Non reactive 
15. Oral cavity 
16. Clubbing 
17. Cyanosis  
18. Lymphadenopathy 
19. Pedal edema 
20. Skin 
VITALS: 
       Pulse 
                          Rate 
                          Rhythum – regular / irregular 
                          Volume – normal/ high / low 
                          Character 
                          Condition of the vessel wall 
                          Peripheral pulse                   felt / not felt         R-R/R-F delay 
Blood pressure: 
                         Supine  
                         Standing 
                         Temperature                           F 
                         Respiratory rate        
  
SYSTEMIC EXAMINATION: 
CVS: 
Inspection 
Palpation 
Percussion 
Auscultation 
ABDOMEN: 
Inspection 
Palpation 
Percussion 
Auscultation 
RS: 
Inspection 
Palpation 
Percussion 
Auscultation 
 
CNS: 
Mental status examination 
Cranial Nerves 
Motor System 
Cerebellar examination 
Meningeal signs 
  
 
CLINICAL DIAGNOSIS: 
INVESTIGATIONS: 
Lipid profile: 
Total cholesterol          : 
Triglycerides                : 
LDL                             : 
HDL                            : 
VLDL             : 
Blood sugar:                       FBS 
  
  
Urine routine: 
Alb                                  : 
Sugar                               : 
Microscopy                       : 
ECG in all leads:   Rate   Rhythm   Axis  P-Wave   P-R Interval QRS Complex 
                                           ST segment  T-Wave  U wave 
CONCLUSION 
 
 
 
Signature of Guide                                                        Signature of Student 
 
 
 
 
 
 
 
 
 
 
 
  
CONSENT FORM 
I am Dr.Nirmala.P, carrying out a study on the topic, "PREVALENCE OF 
HYPERLIPIDEMIA AMONG HEALTHY FEMALES AND THEIR 
RELATIONSHIP WITH WAIST CIRCUMFERENCE AND BODY MASS 
INDEX” 
My research project guide is Dr.S.Usha M.D., My research project is being 
carried out under the department of General Medicine, Coimbatore Medical 
College Hospital. 
RESEARCH BEING DONE: 
"PREVALENCE OF HYPERLIPIDEMIA AMONG HEALTHY FEMALES 
AND THEIR RELATIONSHIP WITH WAIST CIRCUMFERENCE AND 
BODY MASS INDEX” 
PURPOSE OF RESEARCH 
1. To  analyse  the  accuracy  of  retinoscopy  in  acceptance  of  
subjective  refraction. 
2.   To  analyse  accuracy  of  Autorefraction  in  acceptance  of  
subjective  refraction. 
3. To  compare  the  accuracy  of  retinoscopy  and  autorefraction  in  
acceptance  of  sobjective  refraction. 
SAMPLE SIZE:  
  100 Healthy Females  
STUDY PARTICIPANTS: 
Aged 25-60 years asymptomatic healthy females 
 
 
  
LOCATION: 
Master Health Check up, CMCH, Coimbatore. 
PROCEDURES INVOLVED:  
 The research includes Anthropometric indices – Calculation of Body 
Mass Index, Waist Circumforence, Waist Hip Ratio, Blood Pressure 
Measurement, Serum Lipid Profile, Fasting Blood Sugar, Electro 
Cardiogram and detailed history taking including, Past, Personal, Family & 
Diet History. 
 
         You, Shri./ Smt./ Kum. _________________________, aged ____ 
years, D/o / W/o ________________________________________, residing 
at ________________ _______________________________________ are 
requested to be a participant in the research study titled "PREVALENCE OF 
HYPERLIPIDEMIA AMONG HEALTHY FEMALES AND THEIR 
RELATIONSHIP WITH WAIST CIRCUMFERENCE AND BODY MASS 
INDEX” in Government Medical College Hospital, Coimbatore. You satisfy 
eligibility criteria as per the inclusion criteria. You can ask any question or 
seek any clarifications on the study that you may have before agreeing to 
participate. 
 
DECLINE FROM PARTICIPATION 
You are hereby made aware that participation in this study is purely 
voluntary and honorary and that you have the option and the right to decline 
from participation in the study. 
 
 
  
PRIVACY AND CONFIDENTIALITY 
You are hereby assured about your privacy.  Privacy of subject will be 
respected and any information about you or provided by you during the 
study will be kept strictly confidential. 
 
AUTHORIZATION TO PUBLISH RESULTS   
Results of the study may be published for scientific purposes and/or 
presented to scientific groups, however you will not be identified; neither 
will your privacy be breached. 
STATEMENT OF CONSENT 
I, _____________________, do hereby volunteer and consent to participate 
in this study being conducted by Dr.Nirmala.P, I have read and understood 
the consent form / or it has been read and explained to me in my own 
language. The study has been fully explained to me, and I may ask questions 
at any time. 
 
 
Signature / Left Thumb Impression of the Volunteer Date: 
 
Signature and Name of witness     Date: 
  
  
Xg;Gjy; gbtk;; ; ;; ; ;; ; ; 
 
ngah;   : 
 
ghypdk; :       taJ: 
 
Kfthp  : 
 
 
muR Nfhit kUj;Jtf; fy;Yhhpapy; nghJ kUj;Jtj;Jiwapy; 
gl;l Nkw;gbg;G gapYk; khztp kU.ng.eph;kyh mth;fs; Nkw;nfhs;Sk; 
‘MNuhf;fpakhd ngz;fs; kj;jpapy; gutpAs;s mjpfgbahd ; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;
nfhOg;G;;; r;; ;;rj;J>;;;  ,Lg;G ;;; Rw;wsT kw;Wk; cly; epiw FwpaPl;nlz;; ; ; ; P ; ;; ; ; ; P ; ;; ; ; ; P ; ;” 
rk;ge;jkhd Ma;tpy; nra;Kiw kw;Wk; midj;J tpsf;fq;fisAk; 
Nfl;Lf; nfhz;L vdJ re;Njfq;fis njspTgLj;jpf; nfhz;Nld; 
vd;gij njhptpj;Jf; nfhs;fpNwd;. ehd; ,e;j Ma;tpy; KO 
rk;kjj;Jld; kw;Wk; Ra rpe;jidAld; fye;J nfhs;s rk;kjpf;fpNwd;. 
 
          ,e;j Ma;tpy; vd;Dila midj;J tptuq;fs; 
ghJfhf;fg;gLtJld; ,jd; KbTfs; Ma;tpjopy; ntspaplg;gLtjpy; 
Ml;Nrgid ,y;iy vd;gij njhptpj;Jf; nfhs;fpNwd;. ve;j Neuj;jpYk; 
,e;j Ma;tpypUe;J ehd; tpyfpf; nfhs;s vdf;F chpik cz;L 
vd;gijAk; mwpNtd;. 
 
 
ifnahg;gk;/Nuif 
,lk; : 
ehs; : 
 MASTER CHART 
SL  
NO 
NAME  OP.NO AGE OCCUPTN PH  FH PRH DIET T  A WT HT BMI WC TC HDL TG LDL FBS BP WHR 
1 Malar 15377 27 HW N DM NS M N N 56 158 22.48 78 165 45 130 94 98 110/80 0.84 
2 Dhanam 14856 29 HW N NS NS M N N 56 153 23.92 77 154 44 128 84 97 120/70 0.82 
3 Roslin 15677 26 HW N NS NS M N N 45 150 20 75 165 48 128 91 87 110/76 0.76 
4 Nagammal 16778 25 HW N NS NS M N N 68 167 24.46 76 152 45 108 85 88 110/70 0.88 
5 Reshmi 17886 26 BNS N NS NS M N N 45 148 20.54 79 169 47 125 97 90 120/80 0.86 
6 Rithika 15887 27 TAILOR N NS NS V Y N 66 162 25.19 82 212 34 162 145 89 110/82 0.9 
7 Savitha 15634 29 GS N NS NS M Y N 58 158 23.29 76 152 32 115 97 97 130/70 0.76 
8 Lakshmi 15785 28 COOLI N NS NS M N N 52 156 21.39 77 145 40 134 78 98 126/80 0.79 
9 Rekha 17888 27 HW  N NS NS M N N 62 158 24.89 75 148 45 125 78 94 130/70 0.91 
10 Radhika 16509 28 AG N HTN,DM NS M N N 58 156 23.8 73 158 46 121 88 89 120/70 0.88 
11 Latha 18978 29 GS N DM NS V Y Y 68 162 25.95 86 221 36 158 153 139 110/78 0.87 
12 Bindhu 16561 30 COOLI N NS NS M Y N 54 156 22.22 75 158 38 116 97 97 120/70 0.77 
13 Priya 15643 29 HW N NS NS M Y N 55 160 21.48 76 174 51 125 98 82 110/84 0.76 
14 Indhu 14352 26 BNS N NS NS M N N 54 156 23.8 77 169 47 121 98 85 110/80 0.78 
15 Geetha 15634 27 TEACHER N NS NS M N N 54 156 22.22 76 158 46 128 86 88 120/80 0.75 
16 Shobha 18976 29 LABOUR N NS NS M Y N 55 160 21.48 78.5 151 31 128 94 86 110/80 0.76 
17 Banu 17654 29 HW N NS NS M N N 58 168 20.56 77.5 164 45 118 95 88 120/76 0.75 
18 Parvathy 14009 26 HW N NS NS M N N 56 160 21.87 78 154 42 128 86 91 110/84 0.86 
19 Manjula 15897 28 HW N NS NS M N N 62 158 20.56 79 159 46 118 89 86 110/80 0.84 
20 Prema 17658 40 GS N HTN NS V Y N 57 147 26.37 83 230 32 164 165 85 110/70 0.9 
21 Swapna 16543 37 BNS N NS NS M N N 51 151 22.36 75.5 174 54 121 96 82 120/80 0.88 
22 Usha 14532 36 TEACHER N NS NS M N N 56 160 21.87 76.5 152 44 126 83 89 130/70 0.9 
23 Manjula 14543 29 AG N NS NS M N N 62 158 24.83 77 161 45 120 92 87 120/70 0.75 
24 Kannammal 14657 35 HW N DM,IHD NS V Y N 72 160 28.12 83 226 34 158 160 118 136/90 0.91 
 
 25 Saradha 14689 29 GS N DM NS M N N 55 147 25.45 76.5 151 32 112 97 94 120/80 0.9 
26 Sudha 14588 37 HW N NS NS M N N 54 159 22.22 77 156 45 110 89 93 110/70 0.78 
27 Kasthuri 15432 26 TEACHER N NS NS M N N 56 160 21.87 78.5 170 48 125 97 91 110/80 0.76 
28 Shanthi 16543 39 SA N HTN NS M Y Y 66 150 26.66 82 232 35 166 164 89 120/80 0.86 
29 Anitha 13692 27 HW N NS NS M N N 42 154 17.7 77.5 158 32 135 99 90 130/80 0.92 
30 Ganga 18765 35 LABOUR N NS NS M N N 56 158 22.48 74.5 161 42 118 95 95 130/80 0.92 
31 Malathi 16587 29 HW N NS NS M N N 60 162 22.9 75 158 42 128 90 94 110/70 0.91 
32 Mariyammal 18764 36 GS N IHD NS V Y Y 69 157 28.04 84 244 36 164 175 132 140/90 0.92 
33 Bashirabanu 17609 27 SA N NS NS M N N 51 151 22.36 76.5 165 51 126 89 108 120/80 0.86 
34 Savihri 16709 40 TAILOR N NS NS M N N 60 158 24.09 78 155 43 116 89 106 130/80 0.84 
35 Rathna 14500 29 COOLI N NS NS M N N 48 153 20.5 78.5 161 42 118 95 96 120/80 0.86 
36 Mumthaj 13456 29 HW N DM NS M Y N 68 160 26.56 79 154 34 166 95 98 110/70 0.91 
37 Vanitha 19087 25 NURSE N NS NS M N N 58 162 22.13 78.5 162 41 122 97 102 120/80 0.88 
38 Reetu 18769 37 TEACHER N HTN NS V Y N 74 168 26.24 83 228 32 168 162 96 110/70 0.9 
39 Jayaprabha 16755 40 GS N NS NS V N N 60 158 24.09 84 220 33 170 183 108 110/80 0.88 
40 Devaki 17780 27 SA N NS NS M N N 41 155 17.08 78.5 163 44 122 95 95 110/80 0.88 
41 Govindamma 14563 32 SA N NS NS M N N 55 157 22.35 75.5 161 42 122 95 91 120/84 0.76 
42 Chandra 15643 25 CHEF N NS NS M N N 52 158 20.88 76 155 40 123 90 90 110/80 0.84 
43 Kala 16785 34 LABOUR N NS NS M N N 56 158 22.48 77.5 163 45 135 91 99 110/70 0.86 
44 Yamuna 19656 26 HW N NS NS M N N 62 158 24.8 78 169 45 133 97 98 130/70 0.9 
45 Hema 16789 37 TAILOR N HTN NS M Y Y 60 144 28.98 84 224 32 172 157 142 140/88 0.88 
46 Ananthi 14987 26 HW N NS NS M N N 63 160 24.6 78.5 160 42 113 95 106 110/80 0.88 
47 Sahira 15623 28 MANAGER N NS NS M N N 63 160 24.6 79 157 46 125 86 102 120/80 0.87 
48 Sundaram 17654 35 GS N DM NS M Y N 58 148 26.48 83 232 35 174 162 109 110/80 0.91 
49 Pushpam 15467 37 GS N NS NS M N N 62 162 23.6 77.5 163 42 129 95 98 110/70 0.86 
50 Lalitha 16754 26 HW N NS NS M N N 42 150 18.67 77.5 158 35 119 99 89 120/84 0.91 
51 Parimala 15689 39 TEACHER N HTN NS M N N 62 152 26.84 76.5 168 47 120 97 123 110/80 0.89 
52 Indirani 18976 39 CHEF N NS NS M Y N 62 158 24.8 84 165 45 119 96 96 120/84 0.77 
53 Ashabi 18792 27 HW N NS NS M N N 56 163 21.07 77.5 155 35 123 95 105 110/70 0.84 
 54 Mani 18923 35 GS N NS NS M N N 56 160 21.8 77 164 46 129 92 102 120/80 0.9 
55 Shanthi 18543 34 SA N HTN NS V N N 78 170 26.98 83 155 34 123 96 99 110/80 0.88 
56 Revathi 14588 26 COOLI N NS NS M N N 60 170 20.76 76.5 154 31 120 99 97 120/70 0.86 
57 Savithri 20034 26 WAITER N NS NS M N N 62 160 24.21 77 165 45 131 94 99 120/80 0.9 
58 Kamala 20056 27 GS N DM NS M Y N 78 160 30.46 78 156 36 156 94 119 130/84 0.94 
59 Kanimozhi 20076 26 MANAGER N NS NS M Y N 60 152 25.97 78 154 32 170 97 105 110/80 0.88 
60 Raji 22045 27 TAILOR N DM NS M N N 66 150 29.33 78.5 155 31 164 99 109 140/90 0.89 
61 Sujatha 22287 34 BNS N NS NS M Y N 56 158 22.48 77.5 159 42 125 92 101 110/84 0.88 
62 Chandra 21044 27 CHEF N DM NS M N N 74 168 26.24 82 230 35 158 163 99 110/80 0.91 
63 Saraswathi 21055 32 LABOUR N NS NS M N N 58 162 22.13 76.5 164 44 118 96 97 110/70 0.86 
64 Bharathi 24034 25 HW N NS NS M N N 56 157 22.76 77.5 158 41 130 91 98 110/70 0.87 
65 Haseena 25013 33 HW N NS NS M N N 60 160 23.43 78.5 155 43 116 89 90 120/80 0.88 
66 Reeta 24567 28 DHOBI N NS NS M N N 53 158 21.28 78 158 34 126 99 89 128/70 0.84 
67 Kiruthika 22018 35 BNS N DM NS M Y Y 56 154 23.61 82 154 30 125 99 88 120/80 0.9 
68 Dhanalakshmi 22756 27 GS N NS NS M N N 60 156 24.65 77.5 164 47 121 93 88 110/80 0.88 
69 Anushiya 26544 28 GS N NS NS M N N 56 155 23.3 77 163 42 128 95 94 130/80 0.9 
70 Bakkiyam 27698 29 TAILOR N IHD NS M N N 68 160 26.56 83 220 37 162 151 118 120/80 0.91 
71 Gowthami 27756 27 TEACHER N NS NS M N N 58 156 23.83 78.5 160 36 126 99 96 110/70 0.88 
72 Lakshmi 23389 28 WAITER N DM NS M N N 52 156 21.36 81 213 38 156 144 98 110/80 0.86 
73 Narmatha 26656 29 DHOBI N NS NS M N N 45 150 20 77.5 158 35 120 99 105 120/80 0.88 
74 Uma 28765 40 SA N NS NS M Y N 70 168 24.82 79 155 32 121 99 103 110/80 0.92 
75 Vishalatchi 25400 37 GS N NS NS M N N 56 158 22.48 79.5 155 42 124 88 105 120/80 0.91 
76 Sunitha 21987 38 TEACHER N NS NS M N N 60 162 22.9 79 166 45 125 96 96 110/80 0.92 
77 Sanmathi 18765 28 CHEF N HTN NS M N N 56 158 22.48 84 217 36 164 148 133 120/80 0.88 
78 Aswini 15473 27 HW N NS NS M N N 52 158 20.88 79.5 155 32 118 99 105 110/80 0.9 
79 Ranjitham 17864 38 MANAGER N NS NS M Y Y 58 160 22.65 82 162 42 118 96 99 120/80 0.91 
80 Muniyal 16543 39 BNS N HTN NS V Y N 68 155 28.33 78 158 42 175 92 118 150/90 0.92 
81 Neeraja 18700 29 GS N NS NS M N N 62 172 21.01 83 151 31 125 95 90 110/80 0.76 
82 Menaka 18976 35 GS N IHD NS M Y N 68 160 26.56 75.5 161 45 115 93 89 120/70 0.75 
 83 Manjula 18754 28 HW N NS NS V N N 62 172 21.01 79 153 34 166 95 93 110/70 0.87 
84 Haripriya 17653 34 AG N NS NS V N N 68 168 24.11 78.5 165 45 126 95 96 110/80 0.9 
85 Padmini 18799 36 SA N NS NS M Y Y 70 160 27.34 83 153 35 170 93 95 120/80 0.92 
86 Pangajam 17654 37 TAILOR N NS NS V N N 58 170 20.06 79 153 42 118 87 93 110/80 0.9 
87 Gowri 18734 29 TEACHER N DM NS M N N 72 160 28.12 83 208 30 170 144 119 120/80 0.86 
88 Ponni 16543 40 GS N NS NS M N N 52 158 20.88 77.5 168 45 120 99 101 110/70 0.88 
89 Yasodha 18945 28 SA N NS NS M N N 66 170 22.83 78.5 160 46 138 86 105 110/70 0.89 
90 Leelavathy 21765 27 DHOBI N NS NS M N N 72 170 24.9 79 155 34 123 96 99 110/80 0.86 
91 Nalini 27058 35 GS N HTN NS V Y Y 66 150 29.33 83 155 34 178 95 106 150/100 0.91 
92 Radha 23478 26 HW N NS NS M N N 56 154 23.61 76.5 165 46 122 95 101 120/80 0.84 
93 Lakshmi 24536 34 NURSE N HTN NS V N N 69 157 28.04 79.5 159 34 129 99 89 120/80 0.9 
94 Malathi 23478 25 TEACHER N NS NS M N N 56 155 23.3 78 158 34 129 98 90 120/70 0.88 
95 Renuka 23111 34 CHEF N DM NS V Y N 57 147 26.38 84 160 36 186 98 135 110/80 0.9 
96 Suseela 24345 25 GS N NS NS M N N 60 158 24.03 78.5 169 45 129 98 89 120/80 0.87 
97 Haseena 24765 26 HW N NS NS V N N 52 154 21.92 79 166 42 130 98 96 120/70 0.89 
98 Seetha 18976 32 HW N NS NS M N N 56 157 22.76 79.5 153 45 129 82 98 110/80 0.88 
99 Banu 29087 27 HW N HTN NS M N N 78 162 29.77 82 210 30 166 147 99 120/80 0.9 
100 Dhanalakshmi 29078 34 GS N NS NS M N N 60 160 23.43 78.5 166 42 131 98 101 110/80 0.86 
 
  
 KEY TO MASTER CHART 
 
1. SL.NO                         Serial Number 
2. Name                            
3. IP .No                          Inpatient Number 
4. Age                               
5. Sex                               M-Male 
                                     F-Female 
6. Ocpn                             Occupation,      STU-Student                     
                                                                            HW-House Wife                                            
                                                     GS-Government Service  
                                                     BNS-Business      
                                         AG-Agriculture 
                                                 SA-Sales Assistant 
                                         ENG-Engineer       
                                                                        Nurse 
                                                                        Tailor 
                                                                        Dhobi 
                                                                        Waiter   
                                                                             Teacher 
                                                                             Cooli 
                                                                             Chef 
                                                                             Labour 
                                                                            Manager        
                                                                            Typist 
                                                                            Aya 
                                                                            Attender 
 
 
 
 
 7. PH                             Past History,    DM-Diabetes Mellitus,    Y: Yes             
                                                                                                                N: No 
                                                                        HTN- Hypotension,         Y: Yes             
                                                                                                                 N: No 
                                                                IHD- Ischemic heart Disease      Y: Yes             
                                                                                                                N: No 
                                                               MED-Medication If Any         Y: Yes   
                                                                                                                N: No 
8. FH                           Family History,         NS-Nothing significant 
                                                                     HTN- Hypotension 
                                                                     DM-Diabetes Mellitus     
                                                                     IHD- Ischemic heart Disease 
9. PRH                        Personal history,         NS-Nothing significant  
                                Diet                                V- Vegetarian 
                                                                       M- Mixed 
10. S                              Smoking,                        Y- Yes         
                                                                       N- No  
11. A                             Alcoholic                       Y- Yes         
                                                                       N- No 
12. T                              Tobacco chewing          Y- Yes 
                                                                       N- No  
General Physical Examination 
13.  Wt                             Weight 
14.  Ht                              Height 
15.  BMI                          Body Mass Index 
16.  W.C                          Waist Circumference 
17.  H.C                           Hip Circumference 
18.  W/H                          Waist Circumference 
19.  BP                             Blood Pressure            Systolic/ Diastolic 
  
 Investigations 
20. TC                             Total Cholesterol 
21. TGL                           Triglycerides 
22. LDL                           Low Density Lipoprotein 
23. HDL                          High Density Lipoprotein 
24. FBS                           Fasting Blood Sugar 
  
